Monthly Archives: May 2018

Network Marketing Legend Larry Thompson 50 Years In Network Marketing

Larry Thompson is a legend in Network Marketing. Many people want to be a “Mentor of Mentors” Larry is…
Garrett McGrath, president of the Association Of Network Marketing Professionals stated:
50 YEARS of Legendary Mentorship for everyone in our profession…
“The Mentor to the Millionaires”… 50 Years Ago TODAY (May the 4th 2018).
Larry Thompson said “Yes”… and joined a Network Marketing company… and the rest is TRULY history.
From his first Mentor in our profession Bobby Depew… to the great Jim Rohn… to all of the greats of our profession whom he mentored, raised up and poured into who now are elevating and leading our profession to NEW heights… So many of the systems, trainings, culture, truisms and fundamentals that we all take for granted today, came from Larry.
A heartfelt THANK YOU to you, Larry, and your amazing wife & strong partner Taylor Thompson, and your beautiful family.
Here’s to the next 50 Years!!!
Cheers & lots of love and GRATITUDE from millions of us around the world who admire you, respect you, are grateful for you and your ripple effect. We ALL stand on the shoulders of GIANTS.
I could not let THIS May 4th pass without acknowledging my best friend, my business partner , MY

Read more...

Jeunesse Global Ranks In Top 20 On DSN Global 100

For a third year in a row, Jeunesse has placed among the top 20 companies in the Direct Selling News Global 100, ranking No. 18.
The company was recognized Wednesday night for this top-tier ranking and for being selected as one of the Best Places to Work in Direct Selling at the 9th Annual Direct Selling News Global 100 Celebration in Dallas.
Published since 2010, The DSN Global 100 is the publication’s annual list of the top revenue-generating direct selling companies in the world. Jeunesse has ranked on the list for seven consecutive years.
Jeunesse has maintained annual sales of more than $1 billion for the past three years. This stability coupled with a diversified global market presence represents significant upside potential in the company’s ninth year of business and well beyond.
Chief Visionary Officer Scott Lewis commented,
“Appearing in the DSN Global 100’s top 20 for a third year is an honor and a testament to the global family of Jeunesse Distributors and employees who consistently contribute their passion and dedication to our mission to create positive impact in the world.
 
Our growth and stability are based on building a strong culture with clear values and principles, and we could not be more proud of the people who embrace and strengthen this culture every day.”
Jeunesse was one of only 13 companies recognized at the event as a Best Places to Work

Read more...

Rodan + Fields Hit With A Class Action Lawsuit

Skincare product company Rodan + Fields faces a federal class action lawsuit accusing it of violating state consumer protection laws and engaging in fraudulent and unfair marketing of its Lash Boost eye serum.
Rodan + Fields says its $150 Lash Boost gives users “the appearance of lush, longer-looking lashes.” But the suit claims the multilevel marketing company failed to disclose the side effects of a key ingredient in Lash Boost.
The ingredient in question is a chemical called isopropyl cloprostenate, which is a type of medication called a prostaglandin analog. This one is used to treat eye conditions such as glaucoma.
Rodan + Fields omitted information to Lash Boost buyers about the side effects of prostaglandin analogs that are well-known to eye doctors, according to the April 13 court filing in a U.S. District Court in Oakland, California.
“Consumers of Lash Boost … have experienced serious side effects, including change(s) in iris color, eyelid drooping, itchy eyes, eye/lid discoloration, thinning and loss of eyelashes/loss of eyelash hair, eye sensitivity, eye infections, and vision impairment,” the filing says.
Moreover, the suit notes that Allergan’s Latisse, the only Food and Drug Administration-approved medication for “lash enhancement” also contains a prostaglandin analog, but Allergan fully discloses the potential side

Read more...